The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM). These technologies will be evaluated for commercialization feasibility, especially as they relate to providing precision therapy to tackle an unmet need created by the heterogeneity of disease development and response to treatment. Addressing such needs can provide assets tailored to patients’ therapeutic responses that ultimately improve health. To learn more about the hub.
Home / News / From NJBIZ.com: Rutgers ROI Program to integrate strengths in biomedical sciences, expertise in research commercialization
Recent Posts
- Rutgers Physician Assistant Studies is Third in U.S. News and World Report’s Graduate School Rankings.
- Autism Rates Hit Record High, With One in 31 Children Affected, CDC Reports.
- How Much Do You Need to Walk to Offset the Harmful Effects of Sitting? Experts Explain.
- Frequent Use of Antibiotics in Infants and Young Children May Increase Risk for Asthma, Allergies and Other Conditions
- Revealing the Heavy Impacts of Repeated Low-Level Head Traumas.
Categories
- Community (2,260)
- Covid (986)
- CTO Events (6)
- News (2,879)
- Pilots (21)